|
GMAB
|
Genmab A/S
|
US
|
NASDAQ
|
|
GTHX
|
G1 Therapeutics, Inc.
|
US
|
NASDAQ
|
|
HGEN
|
Humanigen, Inc.
|
US
|
NASDAQ
|
|
HOWL
|
Werewolf Therapeutics, Inc.
|
US
|
NASDAQ
|
|
IDRA
|
Idera Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
IGMS
|
IGM Biosciences, Inc.
|
US
|
NASDAQ
|
|
IMTX
|
Immatics N.V.
|
US
|
NASDAQ
|
|
INAB
|
IN8bio, Inc.
|
US
|
NASDAQ
|
|
IOBT
|
IO Biotech, Inc.
|
US
|
NASDAQ
|
|
ISR
|
IsoRay, Inc.
|
US
|
AMEX
|
|
KPTI
|
Karyopharm Therapeutics Inc.
|
US
|
NASDAQ
|
|
LIXT
|
Lixte Biotechnology Holdings, Inc.
|
US
|
NASDAQ
|
|
LPTX
|
LEAP THERAPEUTICS, INC.
|
US
|
NASDAQ
|
|
MACK
|
Merrimack Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
MDNA
|
Medicenna Therapeutics Corp.
|
US
|
NASDAQ
|
|
MEIP
|
MEI Pharma, Inc.
|
US
|
NASDAQ
|
|
MGNX
|
MacroGenics, Inc.
|
US
|
NASDAQ
|
|
MRKR
|
Marker Therapeutics, Inc.
|
US
|
NASDAQ
|
|
MTEM
|
Molecular Templates, Inc.
|
US
|
NASDAQ
|
|
NCNA
|
NuCana plc
|
US
|
NASDAQ
|